GHTC is working to advance new funding and policy solutions to accelerate the development of technologies to fight COVID-19 in low-resource settings and ensure equitable access to these tools. Learn more about our ongoing advocacy work.
Learn moreGHTC has created a new resource tracking the current state of R&D efforts to combat COVID-19. The tracker, which will be updated regularly, includes information on R&D efforts supported by the US government, multilateral institutions, and GHTC member organizations.
ViewThe International Vaccine Institute (IVI) is the world's only international organization devoted exclusively to developing and introducing new and improved vaccines for global public health. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization.
Learn More
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.
Learn More
GHTC Director Jamie Bay Nishi was quoted in an article in the August Bulletin of the World Health Organization (WHO) on accelerating regulatory processes for COVID-19 technologies.
PDF
Today, the European Medicines Agency adopted a positive opinion under Article 58 for use of the monthly dapivirine ring by cisgender women ages 18 and older in developing countries—a move that we at the GHTC applaud as a major milestone for women’s HIV prevention efforts.
Learn more
GHTC joined a scientific community letter to Congressional leaders urging Congress do do everything possible to maintain the United States' membership and funding for the World Health Organization (WHO).
PDF.jpg?width=500&height=500&mode=crop&anchor=center)
IntraHealth International, The Global Fund
Virtual
View.jpg?width=500&height=500&mode=crop&anchor=center)
International Union Against Tuberculosis and Lung Disease
Virtual
View.jpg?width=500&height=500&mode=crop&anchor=center)
American Society of Tropical Medicine & Hygiene
Virtual
View.jpg?width=500&height=500&mode=crop&anchor=center)
Global Health Council
Virtual
View
With support from the US Agency for International Development’s (USAID) Grand Challenges for Development program, global innovators have been designing and scaling up affordable solutions to the world’s most significant global health challenges. With the toll of COVID-19 now intensifying in low- and middle-income countries, many of these innovations are turning their attention to this new challenge.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
.jpg)
The COVID-19 pandemic is a global health crisis affecting populations around the world. GHTC is tracking and responding to the pandemic through US and multilateral efforts.
